Charity Care Spending By Hospitals Plunges

California hospitals are providing significantly less free and discounted care to low-income patients since the Affordable Care Act took effect.

Read More

UnitedHealth Study: Hospital Inpatient Spending from Commercial Plans Tops $200B in 2018

The annual cost of hospital inpatient spending from commercially insured individuals was more than $200 billion last year, according to an insurer study attacking the hospital industry.

Read More

To Save Money, American Patients And Surgeons Meet In Cancun

Donna Ferguson awoke in the resort city of Cancun before sunrise on a sweltering Saturday in July. She wasn’t headed to the beach. Instead, she walked down a short hallway from her Sheraton hotel and into Galenia Hospital.

Read More

Medicare to Cover Expensive Cancer Cell Therapies

Centers for Medicare and Medicaid Services (CMS) on Wednesday said it has finalized a decision to cover expensive cancer cell therapies sold by Gilead Sciences Inc and Novartis AG.

Read More

After Backing Out Two Years Ago, Anthem Prepares to Return to Health Insurance Exchange

The health insurance company Anthem is making preparations to once again offer plans on the state exchange, a reversal of its decision to exit it two years ago over volatility in the individual health insurance marketplace.

Read More

Financial Performance of Medicare Advantage, Individual, and Group Health Insurance Markets

Medicare-for-All proposals have sparked discussion about the role of private health insurance in the U.S. health care system. Some of the current Medicare-for-All proposals would essentially eliminate private insurance.

Read More

As ‘Medicare for All’ Debate Gains Steam, Many Americans Are On The Fence: Survey

Though support or opposition for “Medicare for All” is dominating the 2020 primary headlines, a large group of Americans is more ambivalent about the proposal, a new survey shows. 

Read More

Medicare to Cover Expensive Cancer Cell Therapies

The U.S. Centers for Medicare and Medicaid Services (CMS) on Wednesday said it has finalized a decision to cover expensive cancer cell therapies sold by Gilead Sciences Inc and Novartis AG.

Read More

California AG Takes On ‘Pay for Delay’ Generic Drug Deals

California’s attorney general touted a legal victory last week against drugmakers who he said made secretive, backroom deals to keep less expensive drugs off the market.

Read More

San Jose Sues CVS, Walgreens and Other Drug Distributors, Manufacturers Over Opioids

San Jose has joined cities across the country in calling out the makers and sellers of prescription painkillers like OxyContin and Percocet for furthering the nation’s opioid epidemic.

Read More
arrowcaret-downclosefacebook-squarehamburgerinstagram-squarelinkedin-squarepauseplaytwitter-squareyoutube-square